HopeStage
Back to all studies
CompletedNCT00835627

Sertraline, therapy or both for nonepileptic seizures and trauma symptoms

About this titleRead the official source — NCT00835627
Medication studyAges 18–95United StatesDissociative disorders
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 95 years.

Listed locations
Stanford and 2 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2008
Recruitment status
Completed
Enrollment listed in the registry
38
Sponsor
Rhode Island Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Behavioural, Drug, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 95 Years
Official registry ID
NCT00835627
Official title
Show the full official title

Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Stanford · Cincinnati · Providence

Registry details
Registry conditions (original wording)

Convulsion, Non-Epileptic; Conversion Disorder; Depression; Stress Disorders, Post-Traumatic; Dissociative Disorders

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Rhode Island Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including sertraline.

Who was this study for?

Listed age limits: 18 years to 95 years.

Want to explore more studies?

Explore studies